9:00 - 9:05 am

Joseph Wu, MD, PhD
Director, Stanford Cardiovascular Institute; Simon H. Stertzer, MD, Professor of Medicine and Radiology, Stanford University

9:05 - 9:10 am

Marc Tessier-Lavigne, PhD
President, Stanford University

9:10 - 9:15 am

Lloyd Minor, MD
Dean, Stanford School of Medicine

9:15 - 9:35 am

Brian Kobilka, MD
Helene Irwin Fagan Chair in Cardiology, Stanford University; Nobel prize in 2012
Challenges in Drug Discovery for G Protein Coupled Receptors

9:35 - 9:49 am

Roger Kornberg, PhD
Mrs. George A. Winzer Professor in Medicine, Stanford University; Nobel prize in 2006
New Paradigms in Drug Discovery

9:49 - 10:03 am

Peter Kim, PhD
Virginia and D.K. Ludwig Professor of Biochemistry, Stanford University
Toward a Single-dose, Room-temperature Stable COVID-19 Vaccine

10:03 - 10:25 am

Panel discussion

10:25 - 10:35 am

Break

10:40 - 10:53 am

Young Sohn
Chairman of the Board, HARMAN and Senior Advisor, Samsung Electronics
The Data Journey of the Voice of the Body

10:53 - 11:03 am

Jürgen Eckhardt, MD
Head of Leaps by Bayer
Breaking through Impossible

11:03 - 11:13 am

Carmen Chang, MA, JD
General Partner; Head of Asia, New Enterprise Associates
Venture and Growth Technology and Healthcare at Scale

11:13 - 11:23 am

Nanna Lüneborg, PhD, MBA
Partner, Novo Ventures
Venture Investment in Drug Discovery – A European Perspective

11:23 - 11:40 am

Panel Discussion

11:45 - 12:02 pm

Taiyin Yang, PhD
Executive Vice President, Pharmaceutical Development and Manufacturing, Gilead
Making Medicines – A Partnership

12:02 - 12:20 pm

Stanley T. Crooke, MD, PhD
Ionis Pharmaceuticals Executive Chairman of the Board
RNA Targeted Drug Discovery: From Pipe Dream to Reality

12:20 - 12:33 pm    

Marcus Schindler, PhD
Executive Vice President and CSO of Research & Early Development, Novo Nordisk
Re-defining the Novo Nordisk approach to drug discovery

12:33 - 12:51 pm

Hal Barron, MD
CSO and President, GlaxoSmithKline
Human Genetics, Functional Genomics and AI/ML in Drug Discovery

12:51 - 1:07 pm

Wendy Young, PhD
Senior Vice President, Small Molecule Drug Discovery, Genentech
Drug Discovery: Where are We Headed?

1:07 - 1:30 pm

Panel Discussion

1:30 - 1:45 pm

Break

1:45 - 2:05 pm

Panel Discussion featuring:

Michael Basson, PhD | Senior Editor, Nature Medicine

Orla Smith, PhD | Editor, Science Translational Medicine

Michael Nedelman | CNN Producer

2:10 - 2:15 pm

Philip Pizzo, MD
David and Susan Heckerman Professor and Professor of Microbiology and Immunology, Stanford University
Introduction of Doug Lowy, MD, and John Schiller, PhD

2:15 - 2:35 pm

Doug Lowy, MD
Principal Deputy Director, National Cancer Institute
Awardee Lecture: Virus-like Particle Vaccination for Preventing HPV-Associated Cancers

2:35 - 3:00 pm

John Schiller, PhD
Deputy Chief, Laboratory of Cellular Oncology
Awardee Lecture: Moving Beyond Personalized Therapies for Cancer

3:00 - 3:10 pm

Q&A Session

3:10 - 3:15 pm

Joseph Wu, MD, PhD
Day 1 Closing Remarks

9:00 - 9:05 am

Joseph Wu, MD, PhD

9:05 - 9:27 am

Janet Woodcock, MD
Acting Commissioner, FDA
The Clinical Trial Enterprise: Lessons from a Pandemic

9:27 - 9:41 am

Kathrin Jansen, PhD
Senior Vice President, Head of Vaccine Research and Development, Pfizer
Learnings from the Development of the BNT162b2 mRNA COVID-19 Vaccine

9:41 - 9:50 am

Anne Heatherington, PhD
Senior Vice President, Head of Data Sciences Institute, Takeda
COVID-19: It’s the End of the World as We Know it…

9:50 - 10:25 am

Panel Discussion featuring:

Janet Woodcock, MD | Acting Commissioner, FDA

Kathrin Jansen, PhD | Senior Vice President, Head of Vaccine Research and Development, Pfizer

Anne Heatherington, PhD | Senior Vice President, Head of Data Sciences Institute, Takeda

Mathai Mammen, MD, PhD | Global Head of Research and Development, Janssen

Yvonne Maldonado, MD | Sr Assoc Dean, Faculty Development and Diversity, Taube Professor of Global Health and Infectious Diseases

10:25 - 10:40 am

Break

10:40 - 10:50 am

Fady Malik, MD, PhD
Executive Vice President, Research and Development, Cytokinetics
The Cardiac Myosin Activator, Omecamtiv Mecarbil: From Concept to Clinic

10:50 - 11:02 am

Serge Saxonov, PhD
Co-Founder and CEO, 10x Genomics
Mastering Biology to Advance Human Health

11:02 - 11:12 am

Mir Imran, MS
Chairman and CEO, Rani Therapeutics

11:12 - 11:20 am

Ken Mills
President and CEO, REGENXBIO
A Brief, Recent History of Drug Discovery in AAV Gene Therapy

11:20 - 11:40 am

Panel discussion

11:45 - 12:01 pm

George Yancopoulos, MD, PhD
President & CSO, Regeneron

12:01 - 12:17 pm

Joan Mannick, MD
Head of Research and Development, Life Biosciences
Targeting the Biology of Aging to Prevent or Treat Aging-related Diseases

12:17 - 12:33 pm

Mathai Mammen, MD, PhD
Global Head of Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
Creating Transformational Medicines

12:33 - 12:48 pm

Levi Garraway, MD, PhD
CMO, Genentech
Towards Personalized Healthcare in Therapeutic Development

12:48 - 1:00 pm

Thomas Hudson, MD
Senior Vice President, R&D and Chief Scientific Officer, AbbVie
Data Convergence and Innovation Medicine

1:00 - 1:25 pm

Panel Discussion

1:25 - 1:35 pm

Break

1:40 - 1:53 pm

Helene Gayle, MD, MPH
President & CEO, The Chicago Community Trust
Fireside chat with Woodrow A. Myers, Jr., MD, MBA

1:53 - 2:06 pm

Mark Smith, MD, MBA
Founding President & CEO, California Healthcare Foundation
Disruptive Innovation in Health Care: In Memory of Clayton Christensen

2:06 - 2:24 pm

Elias Zerhouni, MD
Former President for R&D, Sanofi; former Director of the NIH; former U.S. Presidential Science Envoy
Drug Discovery and Bioinnovation: Opportunities and Challenges

2:24 - 2:40 pm

Robert Califf, MD
Head of Strategy and Policy, Verily Life Sciences and Google Health Divisions of Alphabet
The Post-COVID Crisis in CV Disease – Policy Implications

2:40 - 3:00 pm

Panel Discussion

3:00 - 3:05 pm